David Rinaldi
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 20
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 5
- Neutropenia and Cancer Infections 3
-
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Howard A. Burris (9 shared papers)Daniel D. Von Hoff (10 shared papers)John R. Eckardt (9 shared papers)John G. Kuhn (6 shared papers)Chandra P. Belani (9 shared papers)Michael C. Perry (7 shared papers)Geoffrey R. Weiss (8 shared papers)Gladys Rodriguez (8 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Cancer (4 papers)Lung Cancer (3 papers)Annals of Oncology (3 papers)Anti-Cancer Drugs (3 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
David Rinaldi
38 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 79
- Oncology 951
- Pulmonary and Respiratory Medicine 600
- Genetics 151
- Hepatology 84
- Hematology 76
Countries citing papers authored by David Rinaldi
This map shows the geographic impact of David Rinaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rinaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rinaldi more than expected).
Fields of papers citing papers by David Rinaldi
This network shows the impact of papers produced by David Rinaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rinaldi. The network helps show where David Rinaldi may publish in the future.
Co-authors
The 25 scholars most cited alongside David Rinaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 306 | |
| 2 | 2003 | 225 | |
| 3 | 2003 | 175 | |
| 4 | 1999 | 158 | |
| 5 | 1995 | 132 | |
| 6 | 1999 | 118 | |
| 7 | 2008 | 114 | |
| 8 | 2003 | 93 | |
| 9 | 1998 | 74 | |
| 10 | 1996 | 70 | |
| 11 | 1998 | 67 | |
| 12 | 2005 | 43 | |
| 13 | 1999 | 38 | |
| 14 | 1996 | 34 | |
| 15 | 2001 | 32 | |
| 16 | 1999 | 29 | |
| 17 | 2008 | 28 | |
| 18 | 2004 | 22 | |
| 19 | 2003 | 20 | |
| 20 | 1993 | 18 |
About David Rinaldi
David Rinaldi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Surgery, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (9 papers), Lung Cancer Research Studies (5 papers), Neutropenia and Cancer Infections (3 papers), HIV/AIDS drug development and treatment (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Oncology (951 citations), Pulmonary and Respiratory Medicine (600 citations), Genetics (151 citations), Hepatology (84 citations) and Hematology (76 citations). David Rinaldi has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Howard A. Burris, Daniel D. Von Hoff, John R. Eckardt, John G. Kuhn, Chandra P. Belani, Michael C. Perry, Geoffrey R. Weiss, Gladys Rodriguez, Luis Villa and J. Randolph Hecht. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Lung Cancer, Annals of Oncology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.